Literature DB >> 3456169

Ganglioside GM3: an acidic membrane component that increases during macrophage-like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U937.

H Nojiri, F Takaku, Y Terui, Y Miura, M Saito.   

Abstract

When human myeloid and monocytoid leukemic cell lines HL-60 and U937, respectively, were treated with an exogenous sialoglycosphingolipid, ganglioside GM3, in serum-free medium, cell growth was markedly inhibited, and their morphological maturation along a monocytic lineage was observed. In addition to a significant increase in phagocytic and nonspecific esterase activities, marked increase of monocyte-specific surface antigens detectable with monoclonal antibodies such as OKM1 and OKM5 was observed in GM3-fed cells. Other sialoglycosphingolipids with the carbohydrate structure belonging to ganglio-series oligosaccharide, ganglioside GM1 and a brain ganglioside mixture, had no effect on the cell differentiation, showing instead stimulatory actions on the growth of these cell lines. We recently demonstrated that the ganglio-series ganglioside GM3 characteristically increased during macrophage-like cell differentiation of these cell lines. The present results indicate that ganglioside molecular species that specifically increase during monocytic cell differentiation of human myeloid and monocytoid leukemic cell lines may play, in turn, an important role in the differentiation-induction of these cell lines along a monocytic cell lineage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456169      PMCID: PMC322949          DOI: 10.1073/pnas.83.3.782

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity.

Authors:  H P Koeffler; D W Golde
Journal:  Science       Date:  1978-06-09       Impact factor: 47.728

2.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

3.  Incorporation of exogenous glycosphingolipids in plasma membranes of cultured hamster cells and concurrent change of growth behavior.

Authors:  R A Laine; S Hakomori
Journal:  Biochem Biophys Res Commun       Date:  1973-10-01       Impact factor: 3.575

4.  Replacement of serum by insulin and transferrin supports growth and differentiation of the human promyelocytic cell line, HL-60.

Authors:  T R Breitman; S J Collins; B R Keene
Journal:  Exp Cell Res       Date:  1980-04       Impact factor: 3.905

Review 5.  Glycosphingolipids in cellular interaction, differentiation, and oncogenesis.

Authors:  S Hakomori
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

6.  Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester.

Authors:  G Rovera; D Santoli; C Damsky
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

7.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

Authors:  S J Collins; F W Ruscetti; R E Gallagher; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

8.  High resolution preparative column chromatographic system for gangliosides using DEAE-Sephadex and a new porus silica, Iatrobeads.

Authors:  T Momoi; S Ando; Y Magai
Journal:  Biochim Biophys Acta       Date:  1976-09-27

9.  Identification of a population of bipotent stem cells in the HL60 human promyelocytic leukemia cell line.

Authors:  J A Fontana; D A Colbert; A B Deisseroth
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

10.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.

Authors:  T R Breitman; S E Selonick; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  24 in total

Review 1.  Biosynthesis and functions of gangliosides: recent advances.

Authors:  K O Lloyd; K Furukawa
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

Review 2.  The role of globo-series glycolipids in neuronal cell differentiation--a review.

Authors:  T Ariga; R K Yu
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 3.  Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection.

Authors:  Wendy Blay Puryear; Suryaram Gummuluru
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

4.  Localization and imaging of gangliosides in mouse brain tissue sections by laserspray ionization inlet.

Authors:  Alicia L Richards; Christopher B Lietz; James Wager-Miller; Ken Mackie; Sarah Trimpin
Journal:  J Lipid Res       Date:  2012-01-18       Impact factor: 5.922

5.  Combinatorial PCR approach to homology-based cloning: cloning and expression of mouse and human GM3-synthase.

Authors:  D Kapitonov; E Bieberich; R K Yu
Journal:  Glycoconj J       Date:  1999-07       Impact factor: 2.916

6.  Regulation of glycolipid synthesis in HL-60 cells by antisense oligodeoxynucleotides to glycosyltransferase sequences: effect on cellular differentiation.

Authors:  G Zeng; T Ariga; X B Gu; R K Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

Review 7.  Roles of gangliosides in mouse embryogenesis and embryonic stem cell differentiation.

Authors:  Dong Hoon Kwak; Byoung Boo Seo; Kyu Tae Chang; Young Kug Choo
Journal:  Exp Mol Med       Date:  2011-07-30       Impact factor: 8.718

8.  Effects of ganglioside GM3 on phospholipid turnover of human leukemic J6-2 cells.

Authors:  Zhao-Chun Cui; Ke-Li Ma; Xin-Bo Zhang; Nai-Mei Tang
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

9.  Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B.

Authors:  B L Mirkin; S H Clark; C Zhang
Journal:  Cell Prolif       Date:  2002-04       Impact factor: 6.831

10.  Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.

Authors:  Adel Ersek; Ke Xu; Aristotelis Antonopoulos; Terry D Butters; Ana Espirito Santo; Youridies Vattakuzhi; Lynn M Williams; Katerina Goudevenou; Lynett Danks; Andrew Freidin; Emmanouil Spanoudakis; Simon Parry; Maria Papaioannou; Evdoxia Hatjiharissi; Aristeidis Chaidos; Dominic S Alonzi; Gabriele Twigg; Ming Hu; Raymond A Dwek; Stuart M Haslam; Irene Roberts; Anne Dell; Amin Rahemtulla; Nicole J Horwood; Anastasios Karadimitris
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.